Atlas Trials

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Clinical trial NCT05387785 · UNKNOWN

Trial details

NCT number
NCT05387785
Sponsor
Angion Biomedica Corp
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Idiopathic Pulmonary Fibrosis (IPF)
Start date
2022-06-01
Primary completion
2022-11-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.